Lista de obras - Giuseppe Cicero - Dominio Público Uruguay

A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma.

artículo científico publicado en 2006

Aminobisphosphonates as new weapons for gammadelta T Cell-based immunotherapy of cancer.

artículo científico publicado en 2008

Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations

scientific article published on 09 November 2013

Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects.

artículo científico publicado en 2013

Bortezomib: a new pro-apoptotic agent in cancer treatment.

artículo científico publicado en 2010

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas

artículo científico publicado en 2012

Co‐expression of CD133+/CD44+ in human colon cancer and liver metastasis ⬇️

artículo científico publicado el 1 de febrero de 2013

Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.

artículo científico publicado en 2006

Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells

artículo científico publicado en 2013

Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense?

artículo científico

Farletuzumab for NSCLC: exploiting a well-known metabolic pathway for a new therapeutic strategy

artículo científico publicado en 2014

Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer.

artículo científico publicado en 2005

Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers.

artículo científico publicado en 2006

Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?

artículo científico publicado en 2014

Hsp10, Hsp70, and Hsp90 immunohistochemical levels change in ulcerative colitis after therapy

artículo científico publicado en 2011

Hypoxia and human genome stability: downregulation of BRCA2 expression in breast cancer cell lines

artículo científico publicado en 2013

Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?

artículo científico publicado en 2014

In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients

artículo científico publicado en 2010

Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy.

artículo científico publicado en 2015

MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? ⬇️

artículo científico publicado el 12 de noviembre de 2012

Monoclonal antibodies in gastrointestinal cancers.

artículo científico

Pilot study on predictive value of plasmatic levels of 9 angiogenetic biomarkers in selection of patients candidate to prostate biopsy

artículo científico publicado en 2013

Primary Non-Hodgkins lymphoma of the parotid gland

artículo científico publicado en 2011

Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas

artículo científico publicado en 2006

Ramucirumab and its use in gastric cancer treatment.

artículo científico publicado en 2014

Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study

scientific article published on 01 June 2006

Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study.

artículo científico publicado en 2005

Targeted therapies in hepatocellular carcinoma.

artículo científico publicado en 2014

Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence.

artículo científico publicado en 2007

Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer

artículo científico publicado en 2007

The gene expression profile of cumulus cells reveals altered pathways in patients with endometriosis

artículo científico publicado en 2014

The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg? ⬇️

artículo científico publicado el 4 de enero de 2013

The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer population

artículo científico publicado en 2013

The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.

artículo científico

Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway.

artículo científico publicado en 2016

Well-being among Italian medical oncologists: an exploratory study

artículo científico publicado en 2014

Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting.

artículo científico publicado en 2013

Lista de obras de Giuseppe Cicero

A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma.

Aminobisphosphonates as new weapons for gammadelta T Cell-based immunotherapy of cancer.

Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations

Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects.

Bortezomib: a new pro-apoptotic agent in cancer treatment.

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas

Co‐expression of CD133+/CD44+ in human colon cancer and liver metastasis ⬇️

Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.

Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells

Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense?

Farletuzumab for NSCLC: exploiting a well-known metabolic pathway for a new therapeutic strategy

Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer.

Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers.

Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?

Hsp10, Hsp70, and Hsp90 immunohistochemical levels change in ulcerative colitis after therapy

Hypoxia and human genome stability: downregulation of BRCA2 expression in breast cancer cell lines

Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?

In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients

Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy.

MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? ⬇️

Monoclonal antibodies in gastrointestinal cancers.

Pilot study on predictive value of plasmatic levels of 9 angiogenetic biomarkers in selection of patients candidate to prostate biopsy

Primary Non-Hodgkins lymphoma of the parotid gland

Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas

Ramucirumab and its use in gastric cancer treatment.

Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study

Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study.

Targeted therapies in hepatocellular carcinoma.

Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence.

Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer

The gene expression profile of cumulus cells reveals altered pathways in patients with endometriosis

The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg? ⬇️

The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer population

The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.

Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway.

Well-being among Italian medical oncologists: an exploratory study

Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting.